{{Drugbox
| drug_name = 
| IUPAC_name = 4-Chloro-''N''-[3-(4-morpholinyl)propyl]benzamide
| image = Eprobemide.svg
| alt = 
| caption =
<!--Clinical data -->
| tradename = Befol <small>([[Russia|RU]])</small>
| Drugs.com = 
| MedlinePlus = 
| pregnancy_AU = <!-- A / B1 / B2 / B3 / C / D / X -->
| pregnancy_US = <!-- A / B            / C / D / X -->
| pregnancy_category= 
| legal_AU = <!-- S2, S3, S4, S5, S6, S7, S8, S9 or Unscheduled-->
| legal_CA = <!-- OTC, Rx-only, Schedule I, II, III, IV, V, VI, VII, VIII -->
| legal_UK = <!-- GSL, P, POM, CD, CD Lic, CD POM, CD No Reg POM, CD (Benz) POM, CD (Anab) POM or CD Inv POM -->
| legal_US = <!-- OTC / Rx-only / Schedule I, II, III, IV, V -->
| legal_status = Rx-only
| routes_of_administration = [[Mouth|Oral]]
<!--Pharmacokinetic data -->
| bioavailability = 
| protein_bound = 
| metabolism = 
| elimination_half-life = 
| excretion =
<!--Identifiers -->
| CAS_number = 87940-60-1
| ATCvet = 
| ATC_prefix = <!-- 'none' if uncategorised -->
| ATC_suffix = 
| PubChem = 65659
| DrugBank = 
| ChEMBL = 2104298
| synonyms = Befol
| ChemSpiderID = 59094
<!--Chemical data -->
| C=14 | H=19 | Cl=1 | N=2 | O=2
| molecular_weight  = 282.77 g/mol
| smiles = C1COCCN1CCCNC(=O)C2=CC=C(C=C2)Cl
| StdInChI = 1S/C14H19ClN2O2/c15-13-4-2-12(3-5-13)14(18)16-6-1-7-17-8-10-19-11-9-17/h2-5H,1,6-11H2,(H,16,18)
| StdInChIKey = YYFGRAGNYHYWEZ-UHFFFAOYSA-N
}}

'''Eprobemide''' ([[International Nonproprietary Name|INN]]) is a pharmaceutical drug that was used as an [[antidepressant]] in Russia (under the brand name '''Бефол'''/'''Befol''').<ref>{{cite book | title = Dictionary of Pharmacological Agents | volume = 3 | author = C.R. Ganellin, David J. Triggle | page = 811 | year = 1996 | isbn = 978-0412466304}}</ref>  It is a non-competitive [[reversible inhibitor of monoamine oxidase A]]<ref>{{cite journal | pmid = 2054504 | year = 1991 | last1 = Gol'dina | first1 = O.A. | last2 = Moskvitina | first2 = T.A. | last3 = Gankina | first3 = E.M. | last4 = Kirkel' | first4 = A.Z. | last5 = Kamyshanskaia | first5 = N.S. | last6 = Lopatina | first6 = K.I. | last7 = Sokolova | first7 = T.V. | last8 = Zagorevskiĭ | first8 = V.A. | last9 = Val'dman | first9 = A.V. | last10 = Gorkin | first10 = V.Z. | title = The action of befol and its derivatives on monoamine oxidase of different origins | volume = 111 | issue = 3 | pages = 279–280 | journal = Biulleten' eksperimental'noi biologii i meditsiny}}</ref><ref>{{cite journal | last1=Donskaya | first1=N.S. | last2=Antonkina | first2 = O.A. | last3 = Glukhan | first3 = E. N. | last4 = Smirnov | first4 = S. K. | title = Antidepressant Befol Synthesized Via Interaction of 4-Chloro-N-(3-chloropropyl)benzamide with Morpholine|journal=Pharmaceutical Chemistry Journal | date=2004-07-01 | volume=38 | series=0091-150X | issue=7 | pages=381–384 | doi=10.1023/B:PHAC.0000048439.38383.5f | url=https://dx.doi.org/10.1023/B%3APHAC.0000048439.38383.5f|publisher=Kluwer Academic Publishers-Plenum Publishers}}</ref> that exhibits selective action on serotonin deamination.<ref>[http://chem.sis.nlm.nih.gov/chemidplus/rn/87940-60-1 Eprobemide], ChemIDplus</ref> Eprobemide differs from [[moclobemide]] only in linker that connects morpholine fragment with chlorobenzamide—moclobemide has two carbon atoms while eprobemide has three. Its registration was cancelled on December 30, 2003.<ref>{{cite web|title=Befol — 4DOKTOR.RU Drug Information Handbook|url=http://www.4doktor.ru/default.aspx?drugid=35741|accessdate=4 February 2014|language=Russian}}</ref>

==References==
{{Reflist}}

{{Antidepressants}}
{{Monoamine metabolism modulators}}

[[Category:Antidepressants]]
[[Category:Morpholines]]
[[Category:Benzamides]]
[[Category:Chloroarenes]]
[[Category:Russian drugs]]


{{nervous-system-drug-stub}}